# Bristol-Myers Squibb Company (BMY) — Q2-2009 Earnings Results

**Report date:** 2009-07-23 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BMY/earnings/Q2-2009

## Post-Earnings Brief

### Headline

Bristol Myers Squibb Beats on EPS, Stock Up 2.81%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.56 | N/A | +19.15% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management expressed confidence in their product pipeline and market position. They noted the importance of maintaining momentum in their core areas.

**Key quotes:**

> Management highlighted strong performance in key therapeutic areas.

> They emphasized ongoing commitment to innovation and pipeline development.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

This earnings report indicates that Bristol Myers Squibb is performing well, particularly in terms of EPS, which exceeded expectations. The stock reacted positively, rising by 2.81%, likely due to the strong EPS performance and management's optimistic tone regarding their product pipeline. However, the lack of revenue data and guidance may leave some investors cautious about future performance.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BMY/earnings/Q2-2009_